Value through Innovation27 July 2016

Clinical Study Results

  • MEPROFEN ® - Pharyngitis
    Clinical Study Number 1087.7
    Study Indication Pharyngitis
    Product MEPROFEN ®
    Generic Name Ketoprofen
    Lab Code
    Clinical Phase IV
    Study Title

    Efficacy and tolerability of ketoprofen lyisine salt as a mouthwash in acute phlogosis of the pharyngeal cavity; multicentre, randomized, single-blind, parallel-group comparison versus benzidamine hydrochloride. (MISTRAL Mouthwash In Sore Throat Relief: Anti­-Inflammatory vs. Local anesthetic therapy)

    Study Document Trial synopsis 1087.7 english
  • MOBIC ® - Pharyngitis
    Clinical Study Number 107.193
    Study Indication Pharyngitis
    Product MOBIC ®
    Generic Name Meloxicam
    Lab Code
    Clinical Phase IIb
    Study Title

    Double-blind study to compare efficacy and safety of meloxicam 7.5 mg and 15 mg vs. Naproxen sodium 1100 mg in the symptomatic treatment of acute non bacterial pharyngitis or pharyngo-tonsillitis over a period of 5 days

    Study Document Trial synopsis 107.193 english
  • MUCOANGIN ® - Pharyngitis
    Clinical Study Number 18.489
    Study Indication Pharyngitis
    Product MUCOANGIN ®
    Generic Name Ambroxol
    Lab Code
    Clinical Phase III
    Study Title

    Efficacy and tolerability of Ambroxol Lozenges (Mucoangin®) 20 mg in relieving pain of sore throat in patients with acute viral pharyngitis - A randomised, double-blind, placebo- and active-controlled parallel group study.

    Study Document Trial synopsis 18.489_CO english
  • MUCOANGIN ® - Pharyngitis
    Clinical Study Number 18.490
    Study Indication Pharyngitis
    Product MUCOANGIN ®
    Generic Name Ambroxol
    Lab Code
    Clinical Phase IIIb
    Study Title

    Double-blind, randomized, placebo-controlled trial to investigate the efficacy and tolerance of Ambroxol lozenges 20 mg in the treatment of sore throat in patients with acute viral pharyngitis

    Study Document Trial Synopsis 18.490_CO english
  • MUCOANGIN ® - Pharyngitis
    Clinical Study Number 18.487
    Study Indication Pharyngitis
    Product MUCOANGIN ®
    Generic Name Ambroxol
    Lab Code
    Clinical Phase III
    Study Title

    Efficacy and tolerability of Ambroxol Lozenges 20mg in relieving the pain of sore throat in adolescent patients with acute viral pharyngitis - A randomised, double-blind, placebo-controlled parallel group study. AMBROSIA: Ambroxol Lozenges In Sore throat In Adolescents

    Study Document Trial synopsis 18.487_CO english
  • MUCOANGIN ® - Pharyngitis
    Clinical Study Number 18.504
    Study Indication Pharyngitis
    Product MUCOANGIN ®
    Generic Name Ambroxol
    Lab Code
    Clinical Phase II
    Study Title

    A multi-centre, randomised, double-blind, placebo controlled, parallel group dose finding study to assess the efficacy and safety of ambroxol spray (2.5mg, 5mg or 10mg) versus placebo for the temporary relief of sore throat pain in patients with acute pharyngitis

    Study Document Trial synopsis 18.504_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.